A human neutralizing antibody against a conformational epitope shared by oligomeric SARS S1 protein

13Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An antibody phage-display library was constructed from the B cells of convalescent severe acute respiratory syndrome (SARS) patients and screened using inactivated SARS coronavirus (CoV) virions as antigens. More than 80 positive clones were isolated from the library and one of them, scFv H12, was extensively characterized. scFv H12 bound to SARS-CoV with high affinity (equilibrium dissociation constant, Kd=73.5 nM), and neutralized SARS virions in vitro. The facts that scFv H12 bound to the SARS-S1 protein under non-reducing conditions and that it did not bind to monomeric S1 protein under reducing conditions strongly suggest that scFv H12 recognizes a conformational epitope shared by oligomeric S1 proteins. This study should aid in the manufacture of neutralizing antibody, provide a better understanding the immunological characteristics of SARS protein and facilitate the design of a SARS vaccine. © 2006 International Medical Press.

Cite

CITATION STYLE

APA

Duan, J., Ji, X., Feng, J., Han, W., Zhang, P., Cao, W., … Yan, X. (2006). A human neutralizing antibody against a conformational epitope shared by oligomeric SARS S1 protein. Antiviral Therapy, 11(1), 117–123. https://doi.org/10.1177/135965350601100101

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free